Alaway and Eye Inflammation

This page shows results related to Alaway and Eye Inflammation from the FDA Adverse Event Reporting System (AERS). The adverse event Eye Inflammation has been reported to the FDA a total of 10 times for Alaway.

Learn More About Alaway Adverse Events

Safety Comparison of Eye Inflammation in Alaway and Related Drugs

The Proportional Reporting Ratio (PRR) for Alaway and Eye Inflammation is 114. The chart below compares this proportional reporting ratio of Eye Inflammation for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Eye Inflammation.

Eye Inflammation

NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.

People Reporting Eye Inflammation Used Alaway For the Following Reasons

Of those reporting Eye Inflammation, why were they taking Alaway?

Eye Pruritus
Eye Allergy
Ocular Hyperaemia

Scientific Publications on Eye Inflammation

Powered by Google